Pradaxa 110 mg, Kapseln

7680613850167 CH-61385 Kapseln

Associated product:

PRADAXA caps 110 mg 3 x 60 pce
Pradaxa 110 mg, Kapseln
Fiches Amavita / Sun Store / Coop Vitality

Article details

Package size
3 x 60
Selling units
180
Measure
Kapsel(n)
Galenic form
Kapseln
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
26/02/2024
Patient information leaflet
Français
26/02/2024
Patient information leaflet
Italien
26/02/2024
Summary of Product Characteristics
Allemand
26/02/2024
Summary of Product Characteristics
Français
26/02/2024
Summary of Product Characteristics
Italien
26/02/2024

Detailed composition

Substance Quantity Type Category
dabigatranum etexilatum
110.0 MG Substance Wirkstoff (Principe actif)
dabigatrani etexilati mesilas
126.83 MG Substance WIZUS
acaciae gummi
- Substance HNIDK
acidum tartaricum
- Substance HNIDK
hypromellosum
- Substance HNIDK
dimeticonum
- Substance HNIDK
talcum
- Substance HNIDK
hydroxypropylcellulosum
- Substance HNIDK
hypromellosum
- Substance HNIDK
carrageenanum
- Substance HNIDK
kalii chloridum
- Substance HNIDK
E 171
- Substance FNIDK
E 132
- Substance FIMDK
aqua purificata
- Substance HNIDK
lacca
- Substance HNIDK
E 172 (nigrum)
- Substance FTODK
kalii hydroxidum
- Substance HNIDK

Reimbursement information

Public price
CHF 162.70
Specialties list
Yes
Generic
No
SL addition date: 01/12/2013

Authorization holder

Boehringer Ingelheim (Schweiz) GmbH

4057 Basel

Authorization information

Swissmedic authorization number
61385
Drug name
Pradaxa, Kapseln
Galenic form
KAPS
ATC Code
B01AE07
Authorization status
Z
Dispensing category
B
First authorization
29/05/2012
Authorization expiration date
31/12/9999
IT Number
06.03.0.
Domain
Human medicine
Field of application
Prävention von Schlaganfall und systemischer Embolie bei erwachsenen Patienten mit nicht-valvulärem Vorhofflimmern. Behandlung tiefer Venenthrombosen und/oder Lungenembolien. Prävention der rezidivierenden tiefen Venenthrombose und/oder Lungenembolie.

Package details

Description (FR)
PRADAXA caps 110 mg 3 x 60 pce
Description (DE)
PRADAXA Kaps 110 mg 3 x 60 Stk
Market launch
29/05/2012
Narcotic (BTM)
No

Available generics (8)

Dabigatran Sandoz, Hartkapseln
GTIN: 7680686580015
CHF 60.95
View
Dabigatran Sandoz, Hartkapseln
GTIN: 7680686580022
CHF 150.10
View
Dabigatran Sandoz, Hartkapseln
GTIN: 7680686580039
CHF 60.95
View
Dabigatran Sandoz, Hartkapseln
GTIN: 7680686580046
CHF 150.10
View
Dabigatran Spirig HC, Hartkapseln
GTIN: 7680690550011
CHF 60.95
View
Dabigatran Spirig HC, Hartkapseln
GTIN: 7680690550028
CHF 150.10
View
Dabigatran Spirig HC, Hartkapseln
GTIN: 7680690550035
CHF 60.95
View
Dabigatran Spirig HC, Hartkapseln
GTIN: 7680690550042
CHF 150.10
View

Other package sizes (10)

PRADAXA 75 mg caps
None None
GTIN: 7680613850013
Not in V1
PRADAXA 75 mg caps
None None
GTIN: 7680613850020
Not in V1
PRADAXA 75 mg caps
None None
GTIN: 7680613850037
Not in V1
PRADAXA 75 mg caps
None None
GTIN: 7680613850044
Not in V1
PRADAXA 110 mg caps
None None
GTIN: 7680613850068
Not in V1
PRADAXA 110 mg caps
None None
GTIN: 7680613850075
Not in V1
PRADAXA 110 mg caps
None None
GTIN: 7680613850105
Not in V1
PRADAXA 110 mg caps
None None
GTIN: 7680613850143
Not in V1
PRADAXA caps 110 mg 60 pce
60 KAP
GTIN: 7680613850150
View
PRADAXA 150 mg caps
None None
GTIN: 7680613850112
Not in V1
Buy us a coffee Explore the data